Bienville Capital Management’s Biogen BIIB Stock Holding History

Bienville Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,175	Closed	-$314K	–	132
2020 Q2	$314K	Buy	+1,175	New	+$353K	0.03%	97
2019 Q3	–	Sell	-1,536	Closed	-$359K	–	105
2019 Q2	$359K	Buy	1,536 +198	+15%	+$45.7K	0.04%	114
2019 Q1	$316K	Sell	1,338 -9	-0.7%	-$2.83K	0.04%	119
2018 Q4	$405K	Buy	+1,347	New	+$430K	0.08%	88
2018 Q1	–	Sell	-952	Closed	-$303K	–	147
2017 Q4	$303K	Buy	952 +72	+8%	+$23.1K	0.05%	140
2017 Q3	$276K	Hold	880	–	–	0.05%	132
2017 Q2	$239K	Buy	880 +19	+2%	+$5.02K	0.07%	144
2017 Q1	$235K	Hold	861	–	–	0.06%	137
2016 Q4	$244K	Buy	861 +6	+0.7%	+$1.78K	0.05%	119
2016 Q3	$268K	Sell	855 -1	-0.1%	-$296	0.07%	111
2016 Q2	$207K	Buy	+856	New	+$226K	0.06%	109
2016 Q1	–	Sell	-676	Closed	-$207K	–	82
2015 Q4	$207K	Buy	+676	New	+$194K	0.07%	68
2015 Q3	–	Sell	-655	Closed	-$265K	–	75
2015 Q2	$265K	Hold	655	–	–	0.11%	65
2015 Q1	$277K	Sell	655 -1,568	-71%	-$618K	0.16%	36
2014 Q4	$754K	Buy	+2,223	New	+$719K	0.62%	28

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bienville Capital Management's BIIB Position: Q3 2020 in Review

Bienville Capital Management sold out of Biogen (BIIB) in Q3 2020, closing a stake of 1,175 shares — an estimated $314K sold.

Bienville Capital Management first reported a position in BIIB in Q4 2014 and held it in 15 quarters. The position peaked at $754K in Q4 2014. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

Bienville Capital Management reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
Bienville Capital Management sold 1,175 Biogen shares in Q3 2020, an estimated $314K.
Bienville Capital Management first reported a position in Biogen in Q4 2014 and held it in 15 quarters.
Bienville Capital Management's Biogen position peaked at $754K in Q4 2014.
1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Bienville Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.